Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

Siglecs and their roles in the immune system

Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754

The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins

Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354

Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,057

Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor

Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,051

Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins

Varki, A. P. (2007) · Nature · doi:10.1038/nature05816 · Cited by 855

From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins

Korganow, A., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 691

A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission

Tumpey, T. M., Maines, T. R., Hoeven, N. V., Glaser, L. J., Solórzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., et al. (2007) · Science · doi:10.1126/science.1136212 · Cited by 580

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality

Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 413

Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells

Ibricevic, A., Pekosz, A. S., Walter, M. J., Newby, C. M., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 399

Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies

Hematianlarki, M., & Nimmerjahn, F. (2024) · Immunological Reviews · doi:10.1111/imr.13404 · Cited by 30

CHO Glycosylation Mutants as Potential Host Cells to Produce Therapeutic Proteins with Enhanced Efficacy

Zhang, P., Chan, K. F., Haryadi, R., Bardor, M., & Song, Z. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_163 · Cited by 31

The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade

Svetlicky, N., Ortega‐Hernandez, O., Mouthon, L., Guillevin, L., Thiesen, H., Altman, A., Kravitz, M. S., Blank, M., & Shoenfeld, Y. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9842-5 · Cited by 29

Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors

Morgan, S. B., Holzer, B., Hemmink, J. D., Salguero, F. J., Schwartz, J. C., Agatic, G., Cameroni, E., Guarino, B., Porter, E., Rijal, P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00865 · Cited by 29

Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis

Colomb, F., Giron, L. B., Trbojević‐Akmačić, I., Lauc, G., & Abdel‐Mohsen, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00433-w · Cited by 28

A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity

Zhang, X., Owens, J. M., Olsen, H. S., So, E. C., Burch, E. E., McCroskey, M. C., Li, X., Weber, G. L., Bennett, D., Rybin, D. V., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.121905 · Cited by 29

Choice of host cell line is essential for the functional glycosylation of the Fc region of human IgG1 inhibitors of influenza B viruses

Blundell, P. A., Lu, D., Dell, A., Haslam, S., & Pleass, R. J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901145 · Cited by 29

Hyperuricemia is Associated with Immunoglobulin G N -Glycosylation: A Community-Based Study of Glycan Biomarkers

Hou, H., Xu, X., Sun, F., Zhang, X., Dong, H., Wang, L., Ge, S., An, K., Sun, Q., Li, Y., et al. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0004 · Cited by 29

Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy

Herman, J. D., Wang, C., Burke, J. S., Zur, Y., Compere, H., Kang, J., Macvicar, R., Taylor, S., Shin, S. A., Frank, I., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100811 · Cited by 34

bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody‐mediated immune activation and repression

Gordan, S., Biburger, M., & Nimmerjahn, F. (2015) · Immunological Reviews · doi:10.1111/imr.12347 · Cited by 30

Intravenous immunoglobulin in the treatment of neurologic disorders

Živković, S. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12444 · Cited by 29

Lanthanide binding and IgG affinity construct: Potential applications in solution NMR, MRI, and luminescence microscopy

Barb, A. W., Ho, T. G., Flanagan‐Steet, H. R., & Prestegard, J. H. (2012) · Protein Science · doi:10.1002/pro.2133 · Cited by 28

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies

Joao, C. M., Negi, V. S., Kazatchkine, M. D., Bayry, J., & Kaveri, S. V. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701271 · Cited by 28

Structural insights into the mechanisms and specificities of IgG-active endoglycosidases

Du, J. J., Klontz, E. H., Guerin, M. E., Trastoy, B., & Sundberg, E. J. (2019) · Glycobiology · doi:10.1093/glycob/cwz042 · Cited by 26

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection

Gunn, B. M., & Bai, S. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1976580 · Cited by 28

The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells

Costa, A. R., Withers, J., Rodrigues, M. E., McLoughlin, N., Henriques, M., Oliveira, R., Rudd, P. M., & Azeredo, J. (2012) · New Biotechnology · doi:10.1016/j.nbt.2012.12.002 · Cited by 31

The importance of IgG N-glycosylation in Health, Disease, and Neonatal hemochromatosis

Thaçi, K., & Anthony, R. M. (2025) · Glycoscience & Therapy · doi:10.1016/j.glycos.2025.100002 · Cited by 26

6thAnnual European Antibody Congress 2010

Beck, A., & Wurch, T. (2011) · mAbs · doi:10.4161/mabs.3.2.14788 · Cited by 27

B cells are resistant to immunomodulation by ‘IVIg-educated’ dendritic cells

Maddur, M. S., Hegde, P., Sharma, M., Kaveri, S. V., & Bayry, J. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.08.004 · Cited by 27

B cells with regulatory properties in transplantation tolerance

Durand, J. (2015) · World Journal of Transplantation · doi:10.5500/wjt.v5.i4.196 · Cited by 30

Trichinella spiralis Thioredoxin Peroxidase 2 Regulates Protective Th2 Immune Response in Mice by Directly Inducing Alternatively Activated Macrophages

Jin, Q.-W., Zhang, N., Li, W.-H., Qin, H., Liu, Y., Ohiolei, J. A., Niu, D.-Y., Yan, H., Li, L., Jia, W., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02015 · Cited by 25

Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors

Blundell, P. A., Le, N. P. L., Allen, J., Watanabe, Y., & Pleass, R. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.795047 · Cited by 26

Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice

Salinas-Carmona, M. C., Pérez, L. I., Galán-Huerta, K. A., & Vázquez, A. V. (2009) · Autoimmunity · doi:10.1080/08916930903019119 · Cited by 26

Applying quality by design to glycoprotein therapeutics: experimental and computational efforts of process control

Jedrzejewski, P., del Val, I. J., Polizzi, K. M., & Kontoravdi, C. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.4 · Cited by 27

mAbs N-glycosylation: Implications for biotechnology and analytics

Wang, T., Liu, L., & Voglmeir, J. (2022) · Carbohydrate Research · doi:10.1016/j.carres.2022.108541 · Cited by 25

Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection

Trimarco, J. D., Nelson, S. L., Chaparian, R. R., Wells, A. I., Murray, N. B., Azadi, P., Coyne, C. B., & Heaton, N. S. (2022) · Nature Communications · doi:10.1038/s41467-022-34111-0 · Cited by 25

CHO-gmt5, a novel CHO glycosylation mutant for producing afucosylated and asialylated recombinant antibodies

Haryadi, R., Zhang, P., Chan, K. F., & Song, Z. (2012) · Bioengineered · doi:10.4161/bioe.22262 · Cited by 27

FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt

Eyada, T. K., Farawela, H. M., Khorshied, M. M., Shaheen, I. A. E.-M., Selim, N. M., & Khalifa, I. A. (2011) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32834ddf2f · Cited by 26

The Expanding Role of Therapeutic Antibodies

Salemi, S., Marković, M., Martini, G., & D’Amelio, R. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2013.863304 · Cited by 26

At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody

Yu, C., Gao, K., Zhu, L., Wang, W., Wang, L., Zhang, F., Liu, C., Li, M., Wormald, M. R., Rudd, P. M., et al. (2016) · Scientific Reports · doi:10.1038/srep20029 · Cited by 26

Mixed Zwitterion-Based Self-Assembled Monolayer Interface for Impedimetric Glycomic Analyses of Human IgG Samples in an Array Format

Bertók, T., Dosekova, E., Belický, Š., Holazová, A., Lorencová, L., Mislovičová, D., Paprčková, D., Vikartovská, A., Plička, R., Krejčí, J., et al. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b01456 · Cited by 26

Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation

Brückner, C., Lehmann, C. H. K., Dudziak, D., & Nimmerjahn, F. (2017) · International Immunology · doi:10.1093/intimm/dxx053 · Cited by 26

Animal models of immune thrombocytopenia (ITP)

Semple, J. W. (2010) · Annals of Hematology · doi:10.1007/s00277-009-0882-8 · Cited by 26

The pathogenesis of neonatal autoimmune and autoinflammatory diseases: A comprehensive review

Chang, C. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.010 · Cited by 25

Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications

Saeui, C. T., Urias, E., Liu, L., Mathew, M. P., & Yarema, K. J. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9583-9 · Cited by 25

Review: Intravenous Immunoglobulin and B Cells: When the Product Regulates the Producer

Séïté, J.-F., Hillion, S., Harbonnier, T., & Pers, J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38910 · Cited by 25

Autoantibodies targeting tumor-associated antigens in metastatic cancer

Oaks, M. K., Taylor, S. R., & Shaffer, J. (2013) · OncoImmunology · doi:10.4161/onci.24841 · Cited by 26

Mouse Models of Autoimmune Diseases: Immune Thrombocytopenia

Neschadim, A., & Branch, D. R. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150316123436 · Cited by 25

Fc-gamma receptors: Attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs

Bosques, C. J., & Manning, A. M. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.035 · Cited by 25

Dose‐dependent inhibition of demyelination and microglia activation by IVIG

Winter, M., Baksmeier, C., Steckel, J., Barman, S., Malviya, M., Harrer‐Kuster, M., Hartung, H., & Goebels, N. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.326 · Cited by 25

The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine

Jegaskanda, S. (2018) · Vaccines · doi:10.3390/vaccines6020027 · Cited by 24

Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors

Cambay, F., Raymond, C., Brochu, D., Gilbert, M., Tu, T.-M., Cantin, C., Lenferink, A. E. G., Grail, M., Henry, O., Crescenzo, G. D., et al. (2020) · Current Research in Immunology · doi:10.1016/j.crimmu.2020.06.001 · Cited by 24

Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes*

González, J. C., Chakraborty, S., Thulin, N. K., & Wang, T. T. (2022) · Immunological Reviews · doi:10.1111/imr.13109 · Cited by 24

Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases

Chrostek, L., Cylwik, B., Gińdzieńska‐Sieśkiewicz, E., Gruszewska, E., Szmitkowski, M., & Sierakowski, S. (2013) · Rheumatology International · doi:10.1007/s00296-013-2921-y · Cited by 24

Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification

Iwamoto, M., Sekiguchi, Y., Nakamura, K., Kawaguchi, Y., Honda, T., & Hasegawa, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193534 · Cited by 25

Immunoglobulin G glycosylation and its alterations in aging-related diseases

Wu, Y., Zhang, Z., Chen, L., & Sun, S. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024137 · Cited by 24

Intramolecular N-Glycan/Polypeptide Interactions Observed at Multiple N-Glycan Remodeling Steps through [13C,15N]-N-Acetylglucosamine Labeling of Immunoglobulin G1

Barb, A. W. (2014) · Biochemistry · doi:10.1021/bi501380t · Cited by 24

Causal link between immunoglobulin G glycosylation and cancer: A potential glycobiomarker for early tumor detection

Wang, J., Huang, C., Zhou, J., Zhao, K., & Li, Y. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104282 · Cited by 22

Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

Crow, A. R., Song, S. M., Suppa, S. J., Ma, S., Reilly, M. P., André, P., McKenzie, S. E., & Lazarus, A. H. (2010) · Blood · doi:10.1182/blood-2010-05-280115 · Cited by 23

Evolutional and clinical implications of the epigenetic regulation of protein glycosylation

Horvat, T., Zoldoš, V., & Lauc, G. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0039-1 · Cited by 23

Exploring human glycosylation for better therapies

Krasnova, L. B., & Wong, C. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.05.003 · Cited by 23

Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy

Finke, J. M., & Banks, W. A. (2016) · Human Antibodies · doi:10.3233/hab-160306 · Cited by 23

Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection

van Gent, R., Metselaar, H. J., & Kwekkeboom, J. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.01.001 · Cited by 23

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?

Groot, A. S. D., Cousens, L. P., Mingozzi, F., & Martin, W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/493138 · Cited by 23

The Role of Glycosylation in Therapeutic Antibodies

Spearman, M. A., Dionne, B., & Butler, M. (2011) · Cell engineering · doi:10.1007/978-94-007-1257-7_12 · Cited by 24

Influence of glycan modification on IgG1 biochemical and biophysical properties

Pawlowski, J. W., Bajardi-Taccioli, A., Houde, D. J., Feschenko, M. S., Carlage, T., & Kaltashov, I. A. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.12.061 · Cited by 21

Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris

Wang, S., Rong, Y., Wang, Y., Kong, D., Wang, P. G., Chen, M., & Kong, Y. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-1280-0 · Cited by 22

Do different IgG repertoires play a role in B‐ and T‐cell functional modulation during ontogeny? The “hooks without bait” theory

Victor, J. R. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12335 · Cited by 22

Measuring decreased serum IgG sialylation: a novel clinical biomarker of lupus

Chen, X.-X., Chen, Y.-Q., & Ye, S. (2015) · Lupus · doi:10.1177/0961203315570686 · Cited by 22

The therapeutic potential of sialylated Fc domains of human IgG

Pleass, R. J. (2021) · mAbs · doi:10.1080/19420862.2021.1953220 · Cited by 22

Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody

Gupta, A., Kao, K. S., Yamin, R., Oren, D. A., Goldgur, Y., Du, J. J., Lollar, P., Sundberg, E. J., & Ravetch, J. V. (2023) · Nature Communications · doi:10.1038/s41467-023-38453-1 · Cited by 19

Anticorps thérapeutiques et dérivés : une palette de structures pour une pléthore d’indications

Beck, A., Wagner‐Rousset, E., Wurch, T., & Corvaı̈a, N. (2009) · médecine/sciences · doi:10.1051/medsci/200925121024 · Cited by 25

Intravenous Immunoglobulin in the Management of Lupus Nephritis

Wenderfer, S. E., & Thacker, T. (2012) · Autoimmune Diseases · doi:10.1155/2012/589359 · Cited by 21

Rapid Identification of Terminal Sialic Acid Linkage Isomers by Pseudo‐MS3 Mass Spectrometry

Chen, C., Lin, Y., Lin, J., Li, S., Ren, C., Wu, C., & Chen, C. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201400141 · Cited by 21

Solid‐Phase Enzymatic Remodeling Produces High Yields of Single Glycoform Antibodies

Tayi, V. S., & Butler, M. (2017) · Biotechnology Journal · doi:10.1002/biot.201700381 · Cited by 18

Large-scale quantitative isolation of pure protein N-linked glycans

Valk‐Weeber, R. L., Dijkhuizen, L., & van Leeuwen, S. S. (2019) · Carbohydrate Research · doi:10.1016/j.carres.2019.04.011 · Cited by 21

Evaluation of a glycoengineered monoclonal antibody via LC-MS analysis in combination with multiple enzymatic digestion

Liu, R., Giddens, J. P., McClung, C. M., Magnelli, P. E., Wang, L., & Guthrie, E. P. (2015) · mAbs · doi:10.1080/19420862.2015.1113361 · Cited by 20

The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange

Kuhne, F., Bonnington, L. S., Malik, S., Thomann, M., Avenal, C., Cymer, F., Wegele, H., Reusch, D., Mormann, M., & Bulau, P. (2019) · Antibodies · doi:10.3390/antib8040049 · Cited by 21

Functional and structural modifications of influenza antibodies during pregnancy

Jennewein, M. F., Košíková, M., Noelette, F. J., Radvák, P., Boudreau, C. M., Campbell, J. D., Chen, W. H., Xie, H., Alter, G., & Pasetti, M. F. (2022) · iScience · doi:10.1016/j.isci.2022.104088 · Cited by 21

Glycoproteomics-Compatible MS/MS-Based Quantification of Glycopeptide Isomers

Maliepaard, J. C. L., Damen, M. J. A., Boons, G., & Reiding, K. R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c01319 · Cited by 20

Modulation of Dendritic Cells and Regulatory T Cells by Naturally Occurring Antibodies

Kwekkeboom, J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3461-0_10 · Cited by 20

Heparin-induced thrombocytopenia: further evidence for a unique immune response

Pötschke, C., Selleng, S., Bröker, B. M., & Greinacher, A. (2012) · Blood · doi:10.1182/blood-2012-04-419424 · Cited by 20

Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future

Dalakas, M. C. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06832.x · Cited by 20

FcγRIIb on Myeloid Cells and Intrinsic Renal Cells Rather than B Cells Protects from Nephrotoxic Nephritis

Sharp, P. E. H., Martín-Ramírez, J., Mangsbo, S. M., Boross, P., Pusey, C. D., Touw, I. P., Cook, H. T., Verbeek, J. S., & Tarzi, R. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202250 · Cited by 20

One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes

Tong, X., Li, T., Orwenyo, J., Toonstra, C., & Wang, L. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.07.053 · Cited by 20

Functional glycomics: Application to medical science and hepatology

Miyoshi, E., Kamada, Y., & Suzuki, T. (2019) · Hepatology Research · doi:10.1111/hepr.13459 · Cited by 20

Disruption of hepatocyte Sialylation drives a T cell-dependent pro-inflammatory immune tone

Oswald, D. M., Zhou, J. Y., Jones, M. B., & Cobb, B. A. (2020) · Glycoconjugate Journal · doi:10.1007/s10719-020-09918-y · Cited by 21

Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute

Prabagar, M. G., Choi, H., Park, J., Loh, S., & Kang, Y. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0255-4 · Cited by 20

An integrated science-based approach to drug development

Parren, P. W. H. I., & van de Winkel, J. G. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.006 · Cited by 20

Simplifying Glycan Profiling through a High-Throughput Micropermethylation Strategy

Shajahan, A., Supekar, N. T., Chapla, D. G., Heiß, C., Moremen, K. W., & Azadi, P. (2020) · SLAS TECHNOLOGY · doi:10.1177/2472630320912929 · Cited by 19

Neuroinflammation after SCI: Current Insights and Therapeutic Potential of Intravenous Immunoglobulin

Gillespie, E. R., & Ruitenberg, M. J. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6952 · Cited by 20

Sialylated IVIg binding to DC-SIGN+ Hofbauer cells induces immune tolerance through the caveolin-1/NF-kB pathway and IL-10 secretion.

Choi, H., Yang, S.-W., Joo, J., Park, M., Jin, Y.-H., Kim, J.-W., Lee, S.-Y., Lee, S.-V., Yun, T.-J., Cho, M., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109215 · Cited by 18

An Engineered Pathway for Production of Terminally Sialylated N-glycoproteins in the Periplasm of Escherichia coli

Zhu, J., Ruan, Y., Fu, X., Zhang, L.-C., Ge, G.-S., Wall, J., Zou, T., Zheng, Y., Ding, N., & Hu, X.-J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00313 · Cited by 19

Comparison of the glycosylation of in vitro generated polyclonal human IgG and therapeutic immunoglobulins

Ritamo, I., Cloutier, M., Valmu, L., Néron, S., & Räbinä, J. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.10.005 · Cited by 21

Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?

Recher, M., Sahrbacher, U., Bremer, J., Arndt, B., Steiner, U. C., & Fontana, A. (2009) · Rheumatology International · doi:10.1007/s00296-009-1290-z · Cited by 19

Hocheffiziente Synthese von multiantennären “bisected” N‐Glycanen über Imidate

Mönnich, M., Eller, S., Karagiannis, T., Perkams, L., Luber, T., Ott, D., Niemietz, M., Hoffman, J., Walcher, J., Berger, L., et al. (2016) · Angewandte Chemie · doi:10.1002/ange.201604190 · Cited by 18

Teaching tolerance

Cousens, L. P., Mingozzi, F., van der Marel, S., Su, Y. A., Garman, R. D., Ferreira, V., Martin, W. D., Scott, D. W., & Groot, A. S. D. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21405 · Cited by 18

Activating and inhibitory Fcγ receptors in immunotherapy: being the actor or being the target

Abès, R., Dutertre, C., Agnelli, L., & Teillaud, J. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.57 · Cited by 18

Expression of IL4 (VNTR intron 3) and IL10 (-627) Genes Polymorphisms in Childhood Immune Thrombocytopenic Purpura

Makhlouf, M. M., & Elhamid, S. A. (2014) · Laboratory Medicine · doi:10.1309/lmb0qc5t1rxttrzq · Cited by 18

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies

Monnet, C., Jacque, É., de Romeuf, C., Fontayne, A., Abache, T., Fournier, N., Dupont, G., Derache, D., Engrand, A., Bauduin, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728322 · Cited by 17

High‐dose intravenous immunoglobulins for the treatment of dermatological autoimmune diseases

Hoffmann, J. H. O., & Enk, A. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13389 · Cited by 18

Current understanding and future directions

Jolles, S. R. A., Kaveri, S. V., & Orange, J. S. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04029.x · Cited by 17

Anti-Aβ Oligomer IgG and Surface Sialic Acid in Intravenous Immunoglobulin: Measurement and Correlation with Clinical Outcomes in Alzheimer’s Disease Treatment

Kwon, H., Crisostomo, A. C., Smalls, H. M., & Finke, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120420 · Cited by 17

IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids

Jones, M. B. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.03.014 · Cited by 17

Characterization of N-linked intact glycopeptide signatures of plasma IgGs from patients with prostate carcinoma and benign prostatic hyperplasia for diagnosis pre-stratification

Zhang, Y., Lin, T., Zhao, Y. C., Mao, Y., Tao, Y., Huang, Y., Wang, S., Hu, L., Cheng, J., & Yang, H. (2020) · The Analyst · doi:10.1039/d0an00225a · Cited by 17

Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury

Bhargava, R., Upadhyay, R., Zhao, C., Katakam, P. V. G., Wenderfer, S. E., Chen, J., He, H., Cummings, R. D., Tsokos, M., & Tsokos, G. C. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43200 · Cited by 16

The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development

Brady, L. J., Velayudhan, J., Visone, D. B., Daugherty, K. C., Bartron, J. L., Coon, M. E., Cornwall, C., Hinckley, P., & Connell‐Crowley, L. (2015) · mAbs · doi:10.1080/19420862.2015.1016692 · Cited by 16

An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin

Sneed, S. L., Reese, B. B., Laureano, A. F. S., Ratnapriya, S., Fraschilla, I. R., Jeffrey, K. L., Coffey, G., Conley, P. B., & Anthony, R. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172980 · Cited by 16

The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody

Costa, A. R., Withers, J., Rodrigues, M. E., McLoughlin, N., Henriques, M., Oliveira, R., Rudd, P. M., & Azeredo, J. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-25 · Cited by 16

Metabolic Labeling of Glycoconjugates with Photocrosslinking Sugars

Yu, S., Bond, M. R., Whitman, C. M., & Kohler, J. J. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)78026-5 · Cited by 16

with a Recombinant IgG Fc Recapitulation of IVIG Anti-Inflammatory Activity

Anthony, R. M. (2008)

Research Highlights

Okoreeh, M. K., & Luo, X. (2026) · Transplantation · doi:10.1097/tp.0000000000005610

The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors

Jones, A., Marino, A. E., Martynyuk, T., Bournazos, S., & Ravetch, J. V. (2025) · Science · doi:10.1126/science.adv2927 · Cited by 11

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225

Novel Fc receptors mediating the anti-inflammatory properties of IgG

Ravetch, J. V. (2010)